Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ruckser

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Electronic data processing-assisted high dosage therapy with stem cell transplantation at the Donauspital]K H Habertheuer, P Kier, R Ruckser, et al.
Experimental and Clinical Immunogenetics|January 1, 1997
Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patientsE M Kittl, R Ruckser, S Selleny, et al.
Wiener Klinische Wochenschrift|January 1, 1994
[The value of sequential CD 34 measurement for carrying out stem cell pheresis]P Kier, K Huber, R Ruckser, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Tandem transplantation with peripheral autologous hematopoietic blood stem cells in treatment of oncologic and hematologic malignancies. Initial results of the Donauspital, Vienna]R Ruckser, P Kier, C Sebesta, et al.
European Journal of Haematology|November 28, 2001
Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemiaV Buxhofer, R Ruckser, P Kier, et al.
Bone Marrow Transplantation|September 1, 1994
Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humansM Hinterberger-Fischer, P Kier, J Spona, et al.
Acta Medica Austriaca. Supplement|January 1, 2003
[Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors]W Hinterberger, Veronika Buxhofer, E Ogris, et al.
Acta Medica Austriaca. Supplement|March 23, 2001
[High dosage therapy and autologous peripheral stem cell transplantation in breast carcinoma]P Kier, R Ruckser, V Buxhofer, et al.
American Journal of Clinical Oncology|August 24, 2000
Elevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancer: is its modulation a step toward posttransplant immunotherapy?M Hinterberger-Fischer, E Ogris, P Kier, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Electronic data processing-assisted high dosage therapy with stem cell transplantation at the Donauspital]K H Habertheuer, P Kier, R Ruckser, et al.
Experimental and Clinical Immunogenetics|January 1, 1997
Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patientsE M Kittl, R Ruckser, S Selleny, et al.
Wiener Klinische Wochenschrift|January 1, 1994
[The value of sequential CD 34 measurement for carrying out stem cell pheresis]P Kier, K Huber, R Ruckser, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Tandem transplantation with peripheral autologous hematopoietic blood stem cells in treatment of oncologic and hematologic malignancies. Initial results of the Donauspital, Vienna]R Ruckser, P Kier, C Sebesta, et al.
European Journal of Haematology|November 28, 2001
Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemiaV Buxhofer, R Ruckser, P Kier, et al.
Bone Marrow Transplantation|September 1, 1994
Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humansM Hinterberger-Fischer, P Kier, J Spona, et al.
Acta Medica Austriaca. Supplement|January 1, 2003
[Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors]W Hinterberger, Veronika Buxhofer, E Ogris, et al.
Acta Medica Austriaca. Supplement|March 23, 2001
[High dosage therapy and autologous peripheral stem cell transplantation in breast carcinoma]P Kier, R Ruckser, V Buxhofer, et al.
American Journal of Clinical Oncology|August 24, 2000
Elevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancer: is its modulation a step toward posttransplant immunotherapy?M Hinterberger-Fischer, E Ogris, P Kier, et al.
Pageof 2